logo
Plus   Neg
Share
Email

ANI Pharmaceuticals CEO Arthur Przybyl To Depart On May 10 - Quick Facts

ANI Pharmaceuticals, Inc. (ANIP) announced Tuesday that Arthur Przybyl will depart as President and Chief Executive Officer on May 10, 2020 after serving in the roles for 11 years.

The Board and Przybyl have determined that the time is right to transition to new leadership as the Company prepares to launch Cortrophin Gel and expand its portfolio of specialty pharmaceutical products.

The Board of Directors has retained a nationally recognized executive search firm to lead the search for a new President and Chief Executive Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Avalon Furniture is recalling about 9,500 units of Cottage Town Bedroom Furniture collection sold through Rooms To Go due to violation of federal lead paint ban, the U.S. Consumer Product Safety Commission said in a statement. According to the agency, the base coat paint used on pieces within the furniture collection contains levels of lead that exceed the federal lead paint standard. Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints. In the trial, Kevzara was added to best supportive care compared to best supportive care alone (placebo). The companies have stopped the U.S. trial. Shares of Moderna Inc. (MRNA) slipped over 5% on Thursday after a report claimed that the biotechnology company's late-stage trial for a coronavirus vaccine will be delayed. Moderna is developing mRNA-1273 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The...
Follow RTT